Skip to main content
. 2018 Nov 21;8:17174. doi: 10.1038/s41598-018-33873-2

Figure 8.

Figure 8

Targeting of NCL with the AS1411 aptamer inhibits proliferation of pre-B ALL cells. (a) FACS analysis for cell surface NCL in ICN13 cells treated with 15 µM AS1411 or control CRO26. (b,c) Treatment with the indicated concentrations of AS1411 or control CRO26 aptamers for 48 hr in the absence of stroma. (b) total cell number, (c) viability. One experiment of two with different sources of aptamers. Values- mean ± S.E. n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA.